US 10,471,178 B2 · Implantable medical devices with increased immune tolerance, and methods for making and implanting

Abstract

The present invention relates to the contacting of one or more surfaces of an implantable medical device with one or more diketopiperazines (DKPs).

Claims16

Dependent claims

An implantable medical device, wherein a surface of the device comprises components of a filtrate of human serum albumin, wherein one of the components is DA-DKP.

Dependencies are inferred from the claim text.

Facts

Application

15/896,964Filed 14 Feb 2018 · continuation

Priority

10 Oct 2011

Published

US 2019/0022277 A124 Jan 2019

Granted

12 Nov 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61L 27/28
Materials for grafts or prostheses or for coating grafts or prostheses: materials for coating prostheses
A61K 31/495
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with two or more nitrogen atoms as the only ring…
A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61L 27/54
Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface…:…

Family

Application61/545,465Us provisional application · filed 10 Oct 2011

PCT/US2012/059483Parent of this continuation · filed 10 Oct 2012

US 2019/0022277 A1Pre-grant publication · published 24 Jan 2019

Application14/350,617Parent of this continuation

US 9,925,300 B2Parent of this continuation

US 2014/0302114 A1Published application

US 10,471,178 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The present invention relates to the contacting of one or more surfaces of an implantable medical device with one or more diketopiperazines (DKPs).

Facts

Application

15/896,964Filed 14 Feb 2018 · continuation

Priority

10 Oct 2011

Published

US 2019/0022277 A124 Jan 2019

Granted

12 Nov 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61L 27/28
Materials for grafts or prostheses or for coating grafts or prostheses: materials for coating prostheses
A61K 31/495
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with two or more nitrogen atoms as the only ring…
A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61L 27/54
Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface…:…

Family

Application61/545,465Us provisional application · filed 10 Oct 2011

PCT/US2012/059483Parent of this continuation · filed 10 Oct 2012

US 2019/0022277 A1Pre-grant publication · published 24 Jan 2019

Application14/350,617Parent of this continuation

US 9,925,300 B2Parent of this continuation

US 2014/0302114 A1Published application

US 10,471,178 B2This patent

From the US filing history. Foreign family members aren’t listed.

Implantable medical devices with increased immune tolerance, and methods for making and implanting

Life of this patent

Abstract

Claims16

Implantable medical devices with increased immune tolerance, and methods for making and implanting

Life of this patent

Abstract

Claims16